Clinical Trial Update: Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update describes a Phase 2 exploratory trial evaluating the short-term effect on liver enzymes and the safety of TRO19622 in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• TRO19622

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Alcoholic Steatohepatitis (NASH) | Phase 2 | Status: COMPLETED